Genetikailag megváltoztatott dendritikus sejtek és felhasználások rák kezelésére

• 收藏
• 分享

专利权人:

Intrexon Corporation;University of Pittsburgh - Of the Commonwealth System of Higher Education

发明人:

BRAUGHLER, J., Mark,KUMAR, Prasanna,STORKUS, Walter, J.,OKADA, Hideho

申请号：

HUE08836827

公开号：

HUE024479T2

申请日:

2008.10.08

申请国别(地区):

HU

年份:

2016

代理人:

摘要：

This invention provides the field of therapeutics. Most specifically present invention provides methods of generating in vitro engineered dendritic cells conditionally expressing interleukin-12 (IL- 12) under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals including human.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/